PMID- 21705496 OWN - NLM STAT- MEDLINE DCOM- 20111012 LR - 20220316 IS - 1528-0020 (Electronic) IS - 0006-4971 (Print) IS - 0006-4971 (Linking) VI - 118 IP - 7 DP - 2011 Aug 18 TI - Hyperhomocysteinemia increases permeability of the blood-brain barrier by NMDA receptor-dependent regulation of adherens and tight junctions. PG - 2007-14 LID - 10.1182/blood-2011-02-338269 [doi] AB - Hyperhomocysteinemia (HHcy) increases permeability of the blood-brain barrier, but the mechanisms are undetermined. Homocysteine (Hcy) is an agonist of the neuronal N-methyl-D-aspartate receptor (NMDAr). We tested the hypothesis that HHcy disrupts the blood-brain barrier by an NMDAr-dependent mechanism in endothelium. In brain microvascular endothelial cells, there was no change in expression of the adherens junction protein VE-cadherin with Hcy treatment, but there was a significant decrease in the amount of beta-catenin at the membrane. Moreover, Hcy caused nuclear translocation of beta-catenin and attachment to the promoter for the tight junction protein claudin-5, with concomitant reduction in claudin-5 expression. Using a murine model of HHcy (cbs(+/-)), treatment for 2 weeks with an NMDAr antagonist (memantine) rescued cerebrovascular expression of claudin-5 and blood-brain barrier permeability to both exogenous sodium fluorescein and endogenous IgG. Memantine had no effect on these parameters in wild-type littermates. The same results were obtained using an in vitro model with brain microvascular endothelial cells. These data provide the first evidence that the NMDAr is required for Hcy-mediated increases in blood-brain barrier permeability. Modulating cerebral microvascular NMDAr activity may present a novel therapeutic target in diseases associated with opening of the blood-brain barrier in HHcy, such as stroke and dementia. FAU - Beard, Richard S Jr AU - Beard RS Jr AD - Department of Biological Sciences, Idaho State University, Pocatello, ID 83209-8007, USA. FAU - Reynolds, Jason J AU - Reynolds JJ FAU - Bearden, Shawn E AU - Bearden SE LA - eng GR - P20 RR016454/RR/NCRR NIH HHS/United States GR - P20 RR-016454/RR/NCRR NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20110624 PL - United States TA - Blood JT - Blood JID - 7603509 RN - 0 (Antigens, CD) RN - 0 (Cadherins) RN - 0 (Claudin-5) RN - 0 (Cldn5 protein, mouse) RN - 0 (Membrane Proteins) RN - 0 (Receptors, N-Methyl-D-Aspartate) RN - 0 (beta Catenin) RN - 0 (cadherin 5) SB - IM MH - Adherens Junctions/*metabolism MH - Animals MH - Antigens, CD/metabolism MH - Biological Transport MH - Blood-Brain Barrier/*metabolism MH - Cadherins/metabolism MH - Cell Line MH - Claudin-5 MH - Endothelial Cells/metabolism MH - Endothelium, Vascular/metabolism MH - Female MH - Gene Expression Regulation MH - Hyperhomocysteinemia/genetics/*metabolism MH - Male MH - Membrane Proteins/genetics MH - Mice MH - Mice, Inbred C57BL MH - Permeability MH - Receptors, N-Methyl-D-Aspartate/*metabolism MH - Tight Junctions/*metabolism MH - beta Catenin/metabolism PMC - PMC3158726 EDAT- 2011/06/28 06:00 MHDA- 2011/10/13 06:00 PMCR- 2012/08/18 CRDT- 2011/06/28 06:00 PHST- 2011/06/28 06:00 [entrez] PHST- 2011/06/28 06:00 [pubmed] PHST- 2011/10/13 06:00 [medline] PHST- 2012/08/18 00:00 [pmc-release] AID - S0006-4971(20)41116-4 [pii] AID - 2011/338269 [pii] AID - 10.1182/blood-2011-02-338269 [doi] PST - ppublish SO - Blood. 2011 Aug 18;118(7):2007-14. doi: 10.1182/blood-2011-02-338269. Epub 2011 Jun 24.